Expected Tesamorelin to work for visceral fat and it didn't (much)
45 posts
Ran Tesamorelin 2mg/day for 16 weeks. Main goal: visceral fat reduction (DEXA confirmed slight VAT elevation pre-cycle).
Pre: VAT 1.2kg. Post: VAT 1.05kg. Statistically meh.
Side effects were real (fluid retention, some joint stiffness, FBG drift up). Lipids unchanged.
Expected this to be a home run based on the HIV lipodystrophy data. It wasn't. Maybe I was under-VAT to begin with for the drug to show significant effect. Maybe 16 weeks wasn't long enough.
Anyone else have a "I expected this to work and it didn't" experience with Tes?
7 Replies
33 posts
The FBG drift is predictable for any GHRH analog. Not a Tesamorelin-specific failure, just the GH/insulin problem again.
94 posts
At that VAT level diet and training probably would have moved the needle more than Tes. Not a popular answer.
- CJC-1295 no DAC · 100 mcg · pre-bed · sub-Q
- Ipamorelin · 200 mcg · pre-bed · sub-Q
- BPC-157 · 250 mcg · 2x/day · sub-Q
45 posts
Yeah, in retrospect I didn't need the drug. Using it as a VAT tool in someone with moderate VAT was wrong tool wrong target.
25 posts
Appreciate the honesty on a negative result. More of this, less of the 'miracle peptide' posts.
23 posts
Tes at 2mg is the standard lipodystrophy dose. Did you consider a higher dose for a shorter cycle to see if the signal strengthens?
45 posts
I didn't. Tempted but not enough to justify the side effect burden given the modest VAT target to begin with.